- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05641116
Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. (LyMouv')
October 3, 2023 updated by: Centre Hospitalier Universitaire de Saint Etienne
Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. Multicenter, Controlled, Randomized Pilot Study
Lyme borreliosis, commonly known as Lyme disease, has been clinically described for more than a century, but has been officially recognized for 40 years, with the detection of the Borrelia bacterium by W. Burgdorfer, in ticks of the Ixodes ricinus complex, identified a few years before.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Apart from the early localized presentation, with a well established treatment, Lyme borreliosis is a complex infection.
Indeed, its presentation can be late and very polymorphic, which can evoke functional somatic disorders and make its management difficult.
In 2016, the French Ministry of Health decided to launch a national plan to fight Lyme borreliosis.
One of the objectives of this national plan was to improve management based on a specific multidisciplinary care pathway.
Study Type
Interventional
Enrollment (Estimated)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David HUPIN, MD
- Phone Number: +33 0477828413
- Email: David.Hupin@chu-st-etienne.fr
Study Contact Backup
- Name: Elisabeth BOTELHO-NEVERS, MD-PhD
- Phone Number: +33 0477120762
- Email: elisabeth.botelho-nevers@chu-st-etienne.fr
Study Locations
-
-
-
Clermont-Ferrand, France, 63000
- Not yet recruiting
- CHU Clermont-Ferrand
-
Principal Investigator:
- Léo SAUVAT, MD
-
Saint Etienne, France, 42055
- Recruiting
- CHU Saint Etienne
-
Sub-Investigator:
- BOTELHO-NEVERS Élisabeth, PhD
-
Sub-Investigator:
- CAZORLA Céline, MD
-
Principal Investigator:
- David HUPIN, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient referred to the reference center for tick-borne diseases by his attending physician
- Duration of symptoms >6 months
- At the end of the initial assessment, the diagnosis of functional somatic disorders is retained after consensus between the physicians
- Patient practicing less than 150 minutes of regular physical activity per week (WHO recommendations)
Exclusion Criteria:
- Patients with cardiac or respiratory pathologies that contraindicate the practice of physical activity physical activity
- Important comorbidities contraindicating the practice of physical activity: associated cardiac pathologies associated cardiac pathologies (severe rhythm disorders such as rapid atrial fibrillation), respiratory pathologies respiratory pathologies (obstructive or severe restrictive respiratory insufficiency), disabling joint pathologies joint pathologies (gonarthrosis or coxarthrosis limiting training on a treadmill or on a high-intensity bicycle). intensity cycling).
- Patients under guardianship or curatorship
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lyme Borreliosis with physical activity program
Referral of the patient to the sport-health center of his department by the investigating physician (in connection with the attending physician for the prescription of Adaptive Physical Activity): for 24 sessions of APA for 3 months at a rate of 2 sessions/week at the sport and health center + 9 sessions of Therapeutic Patient Education in telecare
|
24 face-to-face APA sessions at the sport and health center for 3 months at a rate of 2 sessions per week near his home and 9 therapeutic patient education workshops for 3 months at a rate of 3 workshops per month (telecare).
|
Other: Lyme Borreliosis patients with physical activity at home
routine clinical practice : encouragement by the attending physician to modify lifestyle habits with advice on resuming regular physical activity independently and combating sedentariness.
At home, in autonomy for 3 months.
|
Advice and recommendations of physical activity at home (= current clinical practice in autonomy for 3 months).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average level of moderate to vigorous physical activity (PA) - MET-h/week
Time Frame: 1 year after implementation of the PA program
|
MET = metabolic equivalent This is measured with actimetry (Actigraph GT3x, Pensacola, Florida, USA). |
1 year after implementation of the PA program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
average level of sedentary lifestyle (h/day)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
|
This is measured with actimetry (Actigraph GT3x, Pensacola, Florida, USA). The average sedentary time measured in industrialized countries is about 4 hours per day (excluding time spent sitting at work and in transport) |
at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Average level of moderate to vigorous physical activity (PA) - MET-h/week
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
|
This measured with Adult Physical Activity Questionnaire (APAQ) Score from 0 to 21 points, 0 = no difficulty, and 21= major difficulties.
|
at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Average level of sedentary lifestyle (h/day)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
|
This measured with Adult Physical Activity Questionnaire (APAQ) Score from 0 to 21 points, 0 = no difficulty, and 21= major difficulties.
|
at Month 3, Month 6 and Month 12 after implementation of the PA program
|
VO2max (in ml/min/kg)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
|
This physical ability is measured with a cardiorespiratory test on a cycloergometer
|
at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Biceps muscular strength (kg)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Muscular strength will be assessed by biceps muscle strength (in kilograms) on the Handgrip (JAMAR Hand Dynamometer, UK)
|
at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Patient Global Impression of Change (PGIC)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Health status will be assessed by the Patient Global Impression of Change (PGIC) and measured on a 7-point Likert scale, rated from 1 for "much worse" to 7 for "much better".
|
at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Psychological distress will be assessed using the Hospital Anxiety and Depression Scale (HADS) The HADS scale has 14 items scored from 0 to 3. 7 questions concern anxiety and 7 others the depressive dimension, which makes it possible to obtain two scores (maximum score for each score = 21).
A score greater than or equal to 11 means that the anxiety or depression is anxiety or depression is certain.
|
at Month 3, Month 6 and Month 12 after implementation of the PA program
|
Number of patients involved in the intervention
Time Frame: at Month 6 after implementation of the PA program
|
Assessment of adherence as measured by the number of patients involved in the intervention
|
at Month 6 after implementation of the PA program
|
medico-economic impact of the care organization
Time Frame: at Month 12 after implementation of the PA program
|
Average cost saved per 100 patients treated in the "physical activity program group" compared to the "control group"
|
at Month 12 after implementation of the PA program
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: David HUPIN, MD, CHU de Saint Etienne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 14, 2023
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
November 8, 2022
First Submitted That Met QC Criteria
November 29, 2022
First Posted (Actual)
December 7, 2022
Study Record Updates
Last Update Posted (Actual)
October 4, 2023
Last Update Submitted That Met QC Criteria
October 3, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- Infections
- Central Nervous System Infections
- Vector Borne Diseases
- Gram-Negative Bacterial Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Central Nervous System Bacterial Infections
- Tick-Borne Diseases
- Spirochaetales Infections
- Lyme Disease
- Borrelia Infections
- Lyme Neuroborreliosis
Other Study ID Numbers
- 22CH398
- 2022-A01120-43 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
Universitaet InnsbruckRecruiting
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
Clinical Trials on physical activity program
-
Universidad Santo TomasEmory University; Universidad Pública de Navarra; Universidad de Granada; University... and other collaboratorsCompletedObesity | Lipid Metabolism Disorders | Mental Health Wellness 1 | Body Composition, Beneficial | Metabolic Syndrome X
-
University Hospital, Clermont-FerrandRecruiting
-
Case Western Reserve UniversityNational Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Assistance Publique Hopitaux De MarseilleNot yet recruiting
-
ElsanNot yet recruitingIndividualised Physical Activity Program | Coronary Patient
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
University Hospital of FerraraUniversità degli Studi di FerraraRecruitingChronic Kidney Disease Stage 5 on DialysisItaly
-
Dokuz Eylul UniversityRecruitingKidney Transplant RecipientsTurkey
-
University Hospital, ToulouseCompletedCOVID-19 InfectionFrance, Guadeloupe
-
University Hospital, LilleWithdrawn